Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mimori

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1996
[Clinical significance of genetic instability in gastrointestinal cancers]M Mori, H Nakashima, K Mimori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancerK Mimori, Y Tanaka, K Yoshinaga, et al.
British Journal of Cancer|July 27, 2007
Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancerY Nakamura, F Tanaka, N Haraguchi, et al.
British Journal of Cancer|June 17, 2004
Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinomaK Ogawa, T Utsunomiya, K Mimori, et al.
International Journal of Cancer|August 22, 1995
Microsatellite instability in Japanese esophageal carcinomaH Nakashima, M Mori, K Mimori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomasM Mori, K Mimori, H Ueo, et al.
Oncology Reports|June 16, 2000
Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinomaH Inoue, K Mimori, T Shiraishi, et al.
International Journal of Cancer|November 4, 2000
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinomaM Mori, K Mimori, N Sadanaga, et al.
International Journal of Oncology|March 16, 2000
alpha6 integrin expression in esophageal carcinomaY Tanaka, K Mimori, T Shiraishi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Cancer-specific chromosome alterations in the constitutive fragile region FRA3BK Mimori, T Druck, H Inoue, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1996
[Clinical significance of genetic instability in gastrointestinal cancers]M Mori, H Nakashima, K Mimori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancerK Mimori, Y Tanaka, K Yoshinaga, et al.
British Journal of Cancer|July 27, 2007
Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancerY Nakamura, F Tanaka, N Haraguchi, et al.
British Journal of Cancer|June 17, 2004
Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinomaK Ogawa, T Utsunomiya, K Mimori, et al.
International Journal of Cancer|August 22, 1995
Microsatellite instability in Japanese esophageal carcinomaH Nakashima, M Mori, K Mimori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomasM Mori, K Mimori, H Ueo, et al.
Oncology Reports|June 16, 2000
Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinomaH Inoue, K Mimori, T Shiraishi, et al.
International Journal of Cancer|November 4, 2000
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinomaM Mori, K Mimori, N Sadanaga, et al.
International Journal of Oncology|March 16, 2000
alpha6 integrin expression in esophageal carcinomaY Tanaka, K Mimori, T Shiraishi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Cancer-specific chromosome alterations in the constitutive fragile region FRA3BK Mimori, T Druck, H Inoue, et al.
Pageof 11